Chiron Real Estate Inc(XRN) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
AI-drawn chart patterns are for reference only.
Full metrics table
| Index | RUT | P/E | 7.61 | EPS (ttm) | 3.5 | Insider Own | 9.71% | Shs Outstand | 13.3M | Perf Week | -12.28% |
| Market Cap | 0.39B | Forward P/E | - | EPS next Y | -167.09% | Insider Trans | 6.83% | Shs Float | 12.0M | Perf Month | -20.52% |
| Enterprise Value | 1.29B | PEG | - | EPS next Q | -0.39 | Inst Own | 74.3% | Short Float | 7.88% | Perf Quarter | -26.52% |
| Income | 0.05B | P/S | 2.36 | EPS this Y | 429.23% | Inst Trans | 6.48% | Short Ratio | 6.68 | Perf Half Y | -21.87% |
| Sales | 0.16B | P/B | 0.82 | EPS next 5Y | 47.72% | ROA | 4.31% | Short Interest | 0.94M | Perf YTD | -21.01% |
| Book/sh | 32.64 | P/C | 15.48 | EPS past 3/5Y | - -1.58% | ROE | 10.13% | 52W High | -31.05% ($38.65) | Perf Year | -18.1% |
| Cash/sh | 1.72 | P/FCF | - | Sales past 3/5Y | 5.52% 11.43% | ROIC | 4.33% | 52W Low | -1.86% ($27.16) | Perf 3Y | -39.74% |
| Dividend Est. | $2.33 (8.72%) | EV/EBITDA | 13.09 | EPS Y/Y TTM | 1512.91% | Gross Margin | 37.05% | Volatility(W/M) | 5.52% 4.02% | Perf 5Y | -65.87% |
| Dividend TTM | 2.3 | EV/Sales | 7.86 | Sales Y/Y TTM | 3.32% | Oper. Margin | 22.71% | ATR (14) | 1.17 | Perf 10Y | -26.76% |
| Dividend Ex-Date | 2026/11/20 | Quick Ratio | 1.09 | EPS Q/Q | -49.39% | Profit Margin | 28.22% | RSI (14) | 28.92 | Recom | 2 |
| Dividend Gr. 3/5Y | -7.72% -3.77% | Current Ratio | 1.09 | Sales Q/Q | 1.31% | SMA20 | -10.37% ($29.73) | Beta | 1.14 | Target Price | $40.25 |
| Payout | - | Debt/Eq | 1.04 | Earnings | 2026/11/4 | SMA50 | -19.67% ($33.18) | Rel Volume | 2.69 | Prev Close | $27.17 |
| Employees | 30 | LT Debt/Eq | 1.04 | EPS/Sales Surpr. | -36.73% -6.04% | SMA200 | -24.06% ($35.09) | Avg Volume(3M) | 0.14M | Price | $26.65 |
| IPO | 2013/6/21 | Option/Short | Yes/Yes | Trades | 3563 | Volume | 380,165 | Change | -1.91% |
🏥 Carelon Real Estate is a net-lease healthcare REIT specializing in medical facilities. It acquires purpose-built healthcare properties—including medical office buildings, rehabilitation hospitals, surgical hospitals, and outpatient treatment facilities—and leases them on a long-term basis to physician groups and regional or national healthcare systems, seeking to generate stable rental income.
Over the past 1 year, on the lower side
31% below its 1-year high.
Traded more than usual. That is 269% of its average volume.
Ex-dividend date: November 20
9 days to go. Buy before this date to receive the dividend.
XRN makes money exceptionally well
Of every $100 in sales, $22.71 is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +429.2% this year.
Tap to view numbers
Within its industry, it looks cheap
For a company earning $100 a year, you would pay $761. Peers typically go for $1,940. Compared with its own 5-year average, it is 85% cheaper now.
Tap to view numbers
Results have missed expectations
Frequently misses analyst estimates
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -65.9%. The S&P 500 did +62% over the same period.
Tap to view numbers
Dividends are paid consistently
Pays 8.72% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 74.3%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #17 of 17 in the industry
Based on market cap of $387M.
FAQ
What kind of company is XRN?
XRN belongs to the Real Estate sector and operates in the REIT - Healthcare Facilities industry.
What is the market cap of XRN?
The market cap of XRN is approximately $387M, ranking 3,359 within its sector.
Does XRN pay dividends?
XRN has a dividend yield of approximately 8.72%, with an annual dividend of $2.33.
What is the P/E ratio of XRN?
XRN has a P/E ratio of approximately 7.6x, which can be used to assess its valuation relative to the Real Estate sector average.
What is the 52-week high and low for XRN?
XRN has recorded a 52-week high of $38.65 and a low of $27.16.
